Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)
Completed · Phase 2 · Has a placebo group
Conditions studied: Major Depressive Disorder
In brief
The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo in participants with MDD on improving symptoms of depression.
Key facts
- Study ID
- NCT05203341
- Run by
- Neurocrine Biosciences
- People needed
- 183
- Starts
- 2022-02-21
- Expected to finish
- 2024-02-21
- Last updated by the study team
- 2025-01-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Neurocrine Clinical Site — Lund, Sweden
- Neurocrine Clinical Site — Birmingham, Alabama, United States
- Neurocrine Clinical Site — Huntsville, Alabama, United States
- Neurocrine Clinical Site — Riverside, California, United States
- Neurocrine Clinical Site — San Diego, California, United States
- Neurocrine Clinical Site — San Francisco, California, United States
- Neurocrine Clinical Site — Torrance, California, United States
- Neurocrine Clinical Site — Hartford, Connecticut, United States
- Neurocrine Clinical Site — Palmetto Bay, Florida, United States
- Neurocrine Clinical Site — Gaithersburg, Maryland, United States
- Neurocrine Clinical Site — Weldon Spring, Missouri, United States
- Neurocrine Clinical Site — Columbus, Ohio, United States
- Neurocrine Clinical Site — North Canton, Ohio, United States
- Neurocrine Clinical Site — Oklahoma City, Oklahoma, United States
- Neurocrine Clinical Site — Memphis, Tennessee, United States
- Neurocrine Clinical Site — Dallas, Texas, United States
- Neurocrine Clinical Site — Houston, Texas, United States
- Neurocrine Clinical Site — Draper, Utah, United States
- Neurocrine Clinical Site — Plovdiv, Bulgaria
- Neurocrine Clinical Site — Rousse, Bulgaria
- Neurocrine Clinical Site — Sofia, Bulgaria
- Neurocrine Clinical Site — Tsarev Brod, Bulgaria
- Neurocrine Clinical Site — Varna, Bulgaria
- Neurocrine Clinical Site — Veliko Tarnovo, Bulgaria
- Neurocrine Clinical Site — Vratsa, Bulgaria
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.